Maria Toki

3.2k citations
33 papers · 1.7k indexed · 1 hit paper · h-index 15
Topics
Cancer Immunotherapy and Biomarkers (18 papers)Immunotherapy and Immune Responses (11 papers)CAR-T cell therapy research (4 papers)
Partner nations
United StatesGreeceChile

In The Last Decade

Maria Toki

33 papers receiving 1.7k citations

Hit Papers

Siglec-15 as an immune suppressor and potential target fo...20192026202120232019100200300400

Peers

Maria Toki
Comparison fields: 5 of 78
  • Oncology 1.0k
  • Immunology 732
  • Molecular Biology 546
  • Pulmonary and Respiratory Medicine 391
  • Cancer Research 240
Replace Daniel Carvajal‐Hausdorf with:
Daniel Carvajal‐Hausdorf United States
Jon Zugazagoitia Spain
Hanqiang Ouyang China
Joyce Sanders Netherlands
Mehrdad Rakaee Norway
Sasha E. Stanton United States
Jason Madore Australia
Zhouzerui Liu United States
Christian von Törne Germany
Rodabe N. Amaria United States
Maria Toki relative to Daniel Carvajal‐Hausdorf United States Daniel Carvajal‐Hausdorf's profile →
Citations per field
00.5×1.5×
Daniel Carvajal‐Hausdorf · 1×
Citations per year

Countries citing papers authored by Maria Toki

Since Specialization
Citations

This map shows the geographic impact of Maria Toki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Toki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Toki more than expected).

Fields of papers citing papers by Maria Toki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Toki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Toki. The network helps show where Maria Toki may publish in the future.

Co-authorship network of co-authors of Maria Toki

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Toki. A scholar is included among the top collaborators of Maria Toki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Toki. Maria Toki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 42
2 13
3 25
4 111
5 103
6
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapybreakdown →
488
7 49
8 69
9 8
10 83
11 82
12 1
13 38
14 108
15 162
16 26
17 3
18 55
19 1
20 11

About Maria Toki

Maria Toki is a scholar working on Oncology, Immunology and Cancer Research, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (732 citations) and Cancer Research (240 citations). Maria Toki has collaborated with scholars based in United States, Greece and Chile. Frequent co-authors include David L. Rimm, Roy S. Herbst, Kurt A. Schalper, James W. Smithy, Lieping Chen, Miguel F. Sanmamed, Mehmet Altan, Konstantinos N. Syrigos, Vasiliki Pelekanou and Konstantinos Syrigos. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026